Ivermectin inhibits epithelial-to-mesenchymal transition via Wnt signaling in endocrine-resistant breast cancer cells.

Ivermectin inhibits epithelial-to-mesenchymal transition via Wnt signaling in endocrine-resistant breast cancer cells.

Show other versions (1)

Ivermectin (IVM), an antiparasitic drug, has been explored for its anticancer properties in various cancer types, including breast cancer. Endocrine therapy resistance poses a significant challenge in breast cancer treatment, often leading to metastasis prevention failure. This study aimed to invest...

Full description

Saved in:
Bibliographic Details
Main Authors: Kitiya Rujimongkon, Patthamapon Adchariyasakulchai, Phum Meeprasertskul, Wannarasmi Ketchart
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0326742
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items